Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.110
-0.140 (-11.20%)
At close: Dec 20, 2024, 4:00 PM
1.100
-0.010 (-0.90%)
After-hours: Dec 20, 2024, 6:49 PM EST
Alzamend Neuro Ratios and Metrics
Market cap in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Dec '24 Dec 20, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
Market Capitalization | 6 | 5 | 53 | 95 | - | - | |
Market Cap Growth | -37.90% | -90.80% | -44.08% | - | - | - | |
Enterprise Value | 2 | 5 | 46 | 83 | - | - | |
Last Close Price | 1.11 | 7.11 | 82.09 | 153.00 | - | - | |
PB Ratio | 1.55 | -1.88 | 17.42 | 7.11 | - | - | |
P/TBV Ratio | 1.87 | - | 17.42 | 7.11 | - | - | |
Debt / Equity Ratio | - | -0.12 | - | - | 0.17 | 0.08 | |
Quick Ratio | 3.26 | 0.12 | 1.79 | 12.07 | 2.16 | 0.19 | |
Current Ratio | 3.80 | 0.14 | 2.03 | 12.37 | 3.24 | 1.83 | |
Return on Equity (ROE) | -1092.96% | -4408.31% | -181.47% | -160.92% | -356.06% | -774.66% | |
Return on Assets (ROA) | -121.64% | -189.73% | -90.97% | -88.35% | -130.96% | -166.83% | |
Return on Capital (ROIC) | -680.83% | -1651.80% | -113.36% | -98.09% | -191.48% | -431.84% | |
Earnings Yield | -97.90% | -203.75% | -28.04% | -13.03% | - | - | |
FCF Yield | -132.73% | -172.40% | -16.82% | -7.08% | - | - | |
Buyback Yield / Dilution | -118.23% | -4.07% | -9.45% | -22.64% | -1.96% | -21.09% | |
Total Shareholder Return | -118.23% | -4.07% | -9.45% | -22.64% | -1.96% | -21.09% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.